F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review the facility failed to ensure drugs and biologicals were labeled in
accordance with currently accepted professional principles for 1 of 2 medication carts (medication aide cart
for the second floor) reviewed for pharmacy services.
The facility failed to ensure a bottle of morphine sulfate in a medication cart on the second floor was
labeled properly in accordance with professional principles for Resident #8 on 1/13/2025. The bottle had a
label without any writing on it.
This failure could place residents at risk for adverse effects and improper administration of medications.
Findings include:
Record review of an admission Record for Resident #8 dated 1/14/2025 indicated she admitted to the
facility on [DATE] and was [AGE] years old with diagnoses of Alzheimer's Disease, hypertensive heart
disease (a condition where high blood pressure makes the heart work harder) and spondylosis (arthritis
that affects the neck and low back).
Record review of active physician orders for Resident #8 dated 1/14/2025 indicated an order for morphine
sulfate oral solution 20 mg/ml give 0.25 ml by mouth every 3 hours as needed for pain that started on
8/28/2024.
Record review of a Quarterly MDS Assessment for Resident #8 dated 12/31/2024 indicated she had severe
impairment in thinking with a BIMS score of 6. She required substantial/maximal assistance with personal
hygiene and showering/bathing. She required set up or clean-up assistance with eating. During the 5 day
look back period she did not receive any PRN pain medication.
Record review of a care plan for Resident #8 dated 10/7/2022 indicated she was on hospice services
related to Alzheimer's. Interventions included to administer pain medication as ordered.
During an observation of the medication cart for the second floor on 1/13/2025 at 10:32 AMMA A was
present and a narcotic count was conducted with the State Surveyor and MA A. A bottle of morphine sulfate
100 mg/5 ml was in a clear, plastic bag prescribed to Resident #8. The plastic bag was labeled with the
resident's name, dosage, date filled, expiration date, pharmacy information, prescribing physician, and
quantity of the medication. The medication bottle inside of the plastic bag had a
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
675964
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675964
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Mrc Creekside
1433 Veterans Memorial Parkway
Huntsville, TX 77340
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
label but the label was blank without any writing on it.
Level of Harm - Minimal harm
or potential for actual harm
During an interview on 1/13/2025 at 10:34 AM, MA A said she had been employed at the facility since
September 2024 and worked 6 am - 2 pm. She said medication bottles should have labels on them and the
bottle of morphine for Resident #8 did not. She said normally the bottles of morphine were in boxes that
were placed inside of a plastic bag and the bag along with the box would be labeled. She said she was not
aware the bottle did not have a label. She said during the narcotic counts conducted with other staff, she
would ensure the quantity of the medication was correct but never noticed that the label did not have any
writing on it. She said she would let LVN B know about the medication. She said she had never given
Resident #8 any of the morphine and the only time the medication was administered was during the
evening shift. She said if a medication was not labeled properly, the resident could potentially be given the
wrong dose or medication.
Residents Affected - Few
During an interview on 1/13/2025 at 10:38 AM, LVN B said she had been employed at the facility for a year
and worked 6 am - 6 pm. She said she was not aware of the morphine for Resident #8 not having a label
on the bottle. She said the bottle should have a label that included the prescriber, resident's name, date
prescribed, date of birth , route, and directions. She said normally if morphine came from the facility
pharmacy, it would be in a box. She said the bottle of morphine for Resident #8 came from the hospice
pharmacy. She said the facility would place the box in a zip lock bag as a safety net. She said if the sticker
fell off the bottle, staff would not have any idea of what the medication was and could potentially cause a
medication error. She said she contacted hospice to notify them as the medication was dispensed through
the hospice pharmacy and they would take care of it.
During an interview on 1/14/2025 at 12:07 PM, the ADON said the medication aides were responsible for
checking the medication carts weekly to ensure medications were properly labeled. She said she was
aware of the bottle of morphine for Resident #8 that was found in the medication cart that was not labeled
properly. She said Resident #8 received the morphine prn and had not received it since September 2024.
She said medications should be labeled with the name of the resident, date it was filled, route to be given,
and dosage to confirm how to be given. She said residents could be at risk of a medication error if
medications were not labeled properly.
During an interview on 1/14/2025 at 12:37 PM, the DON said the medication aides were responsible for
checking the medication carts at least weekly. He said medication bottles should have labels that included
identifier information for the residents that included date filled, route, dose, and time to be given. He said he
was made aware of the bottle of morphine for Resident #8 that was found on yesterday 1/13/2025. He said
the facility started an in-service with the nurses and medication aides for proper labeling of medications. He
said residents could be at risk for medication errors if medications were not labeled properly.
Record review of a facility in-service dated 1/13/2025 titled Medication Aides and Nurses indicated that if
medications had missing/incomplete, improper, or incorrect labels they were to immediately contact the
pharmacy for instruction. The DON conducted the training.
During an interview on 1/14/2025 at 1:36 PM, the Administrator said the medication aides along with the
charge nurses were responsible for checking the medication carts at least weekly. He said his expectations
were to make sure staff were following the proper policy and procedures. He said if staff were not able to
see a label on a prescription, then a resident could be given the wrong medicine.
Record review of a facility policy titled Medical Labeling and Storage revised February 2023
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675964
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675964
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Mrc Creekside
1433 Veterans Memorial Parkway
Huntsville, TX 77340
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
indicated, .Medication Labeling, 1. Labeling of medications and biologicals dispensed by the pharmacy is
consistent with applicable federal and state requirements and currently accepted pharmaceutical practices.
2. The medication label includes, at a minimum: a. medication name (generic and/or brand); b. prescribed
dose; c. strength; d. expiration date, when applicable; e. residents' name; f. route of administration; and g.
appropriate instructions and precautions. 8. If medications containers have missing, incomplete, improper,
or incorrect labels, contact the dispensing pharmacy for instruction regarding returning or destroying these
items. 10. Only the dispensing pharmacy may label or alter the label on a medication container or package .
Event ID:
Facility ID:
675964
If continuation sheet
Page 3 of 3